Company / Operating Cash Flow
Catalyst Pharmaceuticals Partners, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$208.7M
FY2025
5-year range
$60.4M / $239.8M
FY2021-FY2025
Trend
-13.0%
vs FY2024
Sector context
#38 of 216
Health Care
What the data says
Catalyst Pharmaceuticals Partners, Inc.'s operating cash flow of $209M is higher than 82% of companies in the Health Care sector (FY2025). Improved from $144M to $209M over the past 2 years.
Based on SEC 10-K filings.
$209M in FY2025 with a 5-year CAGR of +35.9%. Top quartile in the Health Care sector.
Improved from $144M to $209M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +21.6%
- 5-Year CAGR
- +35.9%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 216This company $208.7M Sector average $658.7M
▼
-68.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +35.9%, indicating consistent growth.
- In FY2025, operating cash flow decreased 13.0% year-over-year.
- Ranks #38 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $208.7M | -13.0% |
| FY2024 | $239.8M | +67.0% |
| FY2023 | $143.6M | +23.7% |
| FY2022 | $116.0M | +92.2% |
| FY2021 | $60.4M | +34.1% |
| FY2020 | $45.0M | +30.1% |
| FY2019 | $34.6M | +232.4% |
| FY2018 | -$26.1M | -45.1% |
| FY2017 | -$18.0M | -0.3% |
| FY2016 | -$18.0M | +0.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026